Cite
Yuen KC, Liu LF, Gupta V, et al. Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2021;27(3):560doi: 10.1038/s41591-021-01246-4.
Yuen, K. C., Liu, L. F., Gupta, V., Madireddi, S., Keerthivasan, S., Li, C., Rishipathak, D., Williams, P., Kadel, E. E., Koeppen, H., Chen, Y. J., Modrusan, Z., Grogan, J. L., Banchereau, R., Leng, N., Thastrom, A., Shen, X., Hashimoto, K., Tayama, D., van der Heijden, M. S., Rosenberg, J. E., McDermott, D. F., Powles, T., Hegde, P. S., Huseni, M. A., & Mariathasan, S. (2021). Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nature medicine, 27(3), 560. https://doi.org/10.1038/s41591-021-01246-4
Yuen, Kobe C, et al. "Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade." Nature medicine vol. 27,3 (2021): 560. doi: https://doi.org/10.1038/s41591-021-01246-4
Yuen KC, Liu LF, Gupta V, Madireddi S, Keerthivasan S, Li C, Rishipathak D, Williams P, Kadel EE, Koeppen H, Chen YJ, Modrusan Z, Grogan JL, Banchereau R, Leng N, Thastrom A, Shen X, Hashimoto K, Tayama D, van der Heijden MS, Rosenberg JE, McDermott DF, Powles T, Hegde PS, Huseni MA, Mariathasan S. Author Correction: High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2021 Mar;27(3):560. doi: 10.1038/s41591-021-01246-4. PMID: 33547461.
Copy
Download .nbib